Mark McDonnell
CFO, CAO and Managing Director
Chicago, Illinois, United States
69 investmentsMark McDonnell is a CFO, CAO and Managing Director based in Chicago, Illinois, United States. Mark McDonnell has backed 69 companies, including KSQ Therapeutics, OncoResponse and Remix Therapeutics. Investment focus areas include Health Care, Medical Testing and Life Science.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (69)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | KSQ Therapeutics | — | — | — | — |
| 2 | OncoResponse | — | — | — | — |
| 3 | Remix Therapeutics | — | — | — | — |
| 4 | LifeMine Therapeutics | — | — | — | — |
| 5 | Cero Therapeutics | — | — | — | — |
| 6 | Encoded Therapeutics | — | — | — | — |
| 7 | Locanabio | — | — | — | — |
| 8 | Faraday Pharmaceuticals | — | — | — | — |
| 9 | AgBiome | — | — | — | — |
| 10 | Metacrine | — | — | — | — |
| 11 | One BioMed | — | — | — | — |
| 12 | Hangzhou Just Biotherapeutics (Just China) | — | — | — | — |
Showing 1–12 of 69
Page 1 of 6
Access Full Contact Information
Get Mark McDonnell's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.